International Forum of Allergy & Rhinology

Papers
(The TQCC of International Forum of Allergy & Rhinology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
International consensus statement on allergy and rhinology: rhinosinusitis 2021460
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023112
International Consensus Statement on Obstructive Sleep Apnea95
Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)79
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant76
Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19)57
International consensus statement on allergy and rhinology: Olfaction53
Diagnosing odontogenic sinusitis: An international multidisciplinary consensus statement53
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps51
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps50
Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view44
A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice40
Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease34
Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps33
Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps31
Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial30
A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis28
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors27
Benefits of biologic therapy administered for asthma on co‐existent chronic rhinosinusitis: A real‐world study26
Effects of olfactory training on posttraumatic olfactory dysfunction: a systematic review and meta‐analysis25
The association of frailty with olfactory and gustatory dysfunction in older adults: a nationally representative sample25
Patient‐reported olfactory recovery after SARS‐CoV‐2 infection: A 6‐month follow‐up study24
The taste of the pandemic—contemporary review on the current state of research on gustation in coronavirus disease 2019 (COVID‐19)24
Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling24
Cryotherapy for treatment of chronic rhinitis: 3‐month outcomes of a randomized, sham‐controlled trial24
Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps24
Making scents of loss of taste in COVID‐19: Is self‐reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing24
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations24
Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps23
Predictors of survival outcomes in sinonasal squamous cell carcinoma: an analysis of the National Cancer Database23
Olfactory cleft mucus inflammatory proteins in CRS: a case‐control study22
Deep learning classification of inverted papilloma malignant transformation using 3D convolutional neural networks and magnetic resonance imaging22
Long‐term olfactory dysfunction in COVID‐19 patients: 18‐month follow‐up study22
The predictive utility of the 22‐item sino‐nasal outcome test (SNOT‐22): A scoping review21
Asthma increases long‐term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis21
Feasibility of a deep learning‐based algorithm for automated detection and classification of nasal polyps and inverted papillomas on nasal endoscopic images21
Parosmia in patients with COVID‐19 and olfactory dysfunction20
Exclusively endoscopic endonasal resection of benign orbital tumors: a systematic review and meta‐analysis20
Revisiting the controversy: The role of fungi in chronic rhinosinusitis19
Comparison of self‐reported symptoms and psychophysical tests in coronavirus disease 2019 (COVID‐19) subjects experiencing long‐term olfactory dysfunction: a 6‐month follow‐up study18
Prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis: a randomized, double‐blind, placebo‐controlled noninferiority clinical trial18
Clinical characteristics and cytokine profiles of central‐compartment‐type chronic rhinosinusitis17
Systematic review of measures of disease severity in rhinitis17
Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence‐Based Review with Recommendations16
Endoscopic sinus surgery for chronic rhinosinusitis: 22‐item Sino‐Nasal Outcome Test 5‐year results16
HPV in the malignant transformation of sinonasal inverted papillomas: A meta‐analysis16
Psychophysical assessment of olfactory and gustatory function in post‐mild COVID‐19 patients: A matched case‐control study with 2‐year follow‐up16
Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID‐19) patients15
Chronic interleukin‐13 expression in mouse olfactory mucosa results in regional aneuronal epithelium15
A comparison of central compartment atopic disease and lateral dominant nasal polyps14
Long‐term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients14
Olfactory dysfunction after coronavirus disease 2019 (COVID‐19) vaccination14
Parosmia assessment with structured questions and its functional impact in patients with long‐term COVID‐19–related olfactory dysfunction13
Eustachian tube dysfunction (ETD) in chronic rhinosinusitis with comparison to primary ETD: A systematic review and meta‐analysis13
Odorant metabolism of the olfactory cleft mucus in idiopathic olfactory impairment patients and healthy volunteers13
GPT‐4 accuracy and completeness against International Consensus Statement on Allergy and Rhinology: Rhinosinusitis13
Systematic review of real‐world persistence and adherence in subcutaneous allergen immunotherapy13
Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once‐daily oral antibiotic treatment for chronic rhinosinusitis13
Temperature‐controlled radiofrequency device treatment of the nasal valve for nasal airway obstruction: A randomized controlled trial13
Surgical repair of nasal septal perforations: A systematic review and meta‐analysis13
Deep learning automated segmentation of middle skull‐base structures for enhanced navigation12
Relationship between socioeconomic status, exposure to airborne pollutants, and chronic rhinosinusitis disease severity12
Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID‐19) patients12
Racial and ethnic disparities in paranasal sinus malignancies12
The clinical effect of psychosomatic interventions on empty nose syndrome secondary to turbinate‐sparing techniques: a prospective self‐controlled study12
Quality‐of‐life instruments in endoscopic endonasal skull base surgery—A practical systematic review12
Differential olfactory outcomes in COVID‐19: A large healthcare system population study12
Assessing health literacy in rhinologic patients12
Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma12
Assessment of patient recognition of coronavirus disease 2019 (COVID‐19)‐associated olfactory loss and recovery: a longitudinal study12
Outcomes of limited versus extensive surgery for chronic rhinosinusitis: A systematic review and meta‐analysis12
Postoperative protocols following endoscopic skull base surgery: An evidence‐based review with recommendations11
Trigeminal features in COVID‐19 patients with smell impairment11
Circadian rhythm disruption exacerbates Th2‐like immune response in murine allergic airway inflammation11
Rhinologic disease and its impact on sleep: a systematic review11
Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis11
The management of cystic fibrosis chronic rhinosinusitis: An evidenced‐based review with recommendations11
Responsiveness and convergent validity of the chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure in CRS patients undergoing endoscopic sinus surgery11
Inflammation‐driven vascular dysregulation in chronic rhinosinusitis10
“Black fungus”: a perspective on the coronavirus disease 2019 (COVID‐19)‐associated rhino‐orbital mucormycosis epidemic in India10
Clinical factors associated with lower health scores in COVID‐19–related persistent olfactory dysfunction10
Olfaction before and after initiation of elexacaftor‐tezacaftor‐ivacaftor in a cystic fibrosis cohort10
Gender and authorship trends in rhinology, allergy, and skull‐base literature from 2008 to 201810
Biologics for chronic rhinosinusitis with nasal polyps: Economics and ethics10
A multicenter real‐life study on the multiple reasons for uncontrolled allergic rhinitis10
Temperature‐controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12‐month outcomes after treatment in a randomized controlled trial10
Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta‐analyses10
Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison10
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients wit9
Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia9
Rhinology Medicare reimbursements have not been keeping up with inflation9
Local nasal immunotherapy for allergic rhinitis: A systematic review and meta‐analysis9
Mental health burden of empty nose syndrome compared to chronic rhinosinusitis and chronic rhinitis9
Heterogeneous distribution of mature olfactory sensory neurons in human olfactory epithelium9
Long‐term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study9
Targetable pathogenic mechanisms in nasal polyposis9
Integrated miRNA and mRNA expression profiling reveals dysregulated miRNA‐mRNA regulatory networks in eosinophilic and non‐eosinophilic chronic rhinosinusitis with nasal polyps9
CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis9
Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study9
ChatGPT‐4 performance in rhinology: A clinical case series9
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps8
Acute invasive fungal sinusitis: Epidemiology and outcomes in the United States8
In vitro evaluation of a novel oxygen‐generating biomaterial for chronic rhinosinusitis therapy8
The digital scent device as a new concept for olfactory assessment8
An algorithm for sellar reconstruction following endoscopic transsphenoidal surgery for pituitary adenoma: A review of 582 cases8
Impact of omalizumab on pollen‐induced seasonal allergic rhinitis: An observational study in clinical practice8
The association of frailty, age, and ASA classification with postoperative outcomes in endoscopic sinus surgery8
In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis8
Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review8
Long‐term outcomes following repair of nasal valve collapse with temperature‐controlled radiofrequency treatment for patients with nasal obstruction8
Predictive value of clinical characteristics in eosinophilic chronic rhinosinusitis with nasal polyps: A cross‐sectional study in the Chinese population8
Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization8
Chronic rhinosinusitis could increase the risk of cholesteatoma of middle ear8
The 15° reverse Trendelenburg position can improve visualization without impacting cerebral oxygenation in endoscopic sinus surgery—A prospective, randomized study8
Prospective assessment of smell and taste impairment in a South‐American coronavirus disease 2019 (COVID‐19) cohort: Association with the need for hospitalization and reversibility of dysfunction8
Private payer‐negotiated prices for FDA‐approved biologic treatments for allergic diseases7
American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery7
The association of active and passive tobacco smoke exposure with chronic rhinosinusitis symptom severity: A cross‐sectional study7
Influence of facility volume and type on esthesioneuroblastoma treatment and outcomes7
Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population7
Correlation between middle turbinate insertion in relation to sphenopalatine foramen and failure rates of cryotherapy and radiofrequency treatment for chronic rhinitis7
Improvement in sinonasal quality‐of‐life indicators for pediatric patients with cystic fibrosis treated with elexacaftor‐tezacaftor‐ivacaftor7
Deep learning‐based prediction of treatment prognosis from nasal polyp histology slides7
Inflammatory endotype of odontogenic sinusitis7
Olfactory cleft mucus proteome in chronic rhinosinusitis: a case‐control pilot study7
The cost of rhinitis in the United States: a national insurance claims analysis7
Association between social determinants of health and olfactory function: a scoping review7
Objective and patient‐based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy7
Usefulness of intraoperative frozen section for diagnosing acute invasive fungal rhinosinusitis: A systematic review and meta‐analysis7
Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies7
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐527
Similarities between allergen sensitivity patterns of central compartment atopic disease and allergic rhinitis6
What is allergic fungal sinusitis: A call to action6
Sox2 regulates globose basal cell regeneration in the olfactory epithelium6
What do we mean when we have a “sinus infection?”6
Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients6
Avoiding bias in artificial intelligence6
Tween 80 and its derivative oleic acid promote the growth of Corynebacterium accolens and inhibit Staphylococcus aureus clinical isolates6
Exploring possibilities for shortening the 22‐item Sino‐Nasal Outcome Test (SNOT‐22) using item response theory6
Oral corticosteroid use and the risk of developing avascular necrosis: A large retrospective review6
Clinical characteristics of central compartment atopic disease in Southern China6
Calprotectin in chronic rhinosinusitis eosinophil extracellular traps6
Nasal cytology in allergic rhinitis: Rare observation of pollen degranulation6
Upper airway microbiome transplantation for patients with chronic rhinosinusitis6
Hypothalamic‐pituitary‐adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta‐analysis6
Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta‐analysis of randomized controlled trials6
Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control6
The empty nose syndrome 6‐item questionnaire (ENS6Q): a diagnostic tool to distinguish empty nose syndrome from primary nasal obstruction6
Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study6
Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database6
Machine learning evaluates improvement in sinus computed tomography opacification with CFTR modulator therapy6
The Omicron variant of SARS‐CoV‐2 and its effect on the olfactory system6
Risk of new‐onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study6
Fungal sinusitis: a spectrum of disease6
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations6
Intramuscular corticosteroid injections should be an option under the policy level recommendation in the International Consensus Statement on Allergic Rhinitis6
Omalizumab and quality of life in nasal polyps: A post hoc analysis6
Disease involvement in the central compartment in eosinophilic chronic rhinosinusitis5
Evaluating inflammation in an obstruction‐based chronic rhinosinusitis model in rabbits5
Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery5
Comparison of high‐flow CSF leak closure with nasoseptal flap following endoscopic endonasal approach in adult and pediatric populations5
Venous thromboembolism rates and risk factors following endoscopic skull base surgery5
Endoscopic surgery is superior to intensity‐modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma5
Particulate matter air pollution exposure disrupts the Nrf2 pathway in sinonasal epithelium via epigenetic alterations in a murine model5
Self‐reported olfactory and gustatory dysfunction and psychophysical testing in screening for COVID‐19: A systematic review and meta‐analysis5
Effect of the COVID‐19 pandemic on the mental health, daily and occupational activities of otolaryngologists and allergists in Colombia: a national study5
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy5
Prophylactic and therapeutic topical povidone‐iodine in coronavirus disease 2019 (COVID‐19): What is the evidence?5
Climate change, the environment, and rhinologic disease5
Influence of omalizumab on treatment costs for chronic rhinosinusitis with nasal polyps and asthma: an insurance claims analysis5
Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy5
The association of gustatory dysfunction, olfactory dysfunction, and cognition in older adults5
Outcomes of endoscopic endonasal resection of pediatric craniopharyngiomas5
Postnasal drip and chronic cough in patients with chronic rhinitis treated with temperature‐controlled radiofrequency neurolysis5
Histopathologic differences between adult and pediatric patients with chronic rhinosinusitis5
Primary sinonasal lymphoma: A multi‐institutional experience of clinical presentation, treatment, and outcomes5
Taste receptors in chronic rhinosinusitus, what is the evidence? A systematic review5
Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del5
Gender‐related differences in outcomes after endoscopic sinus surgery5
Dupilumab‐related adverse events among patients with chronic rhinosinusitis with nasal polyposis5
Biological sex as a modulator in rhinologic anatomy, physiology, and pathology: A scoping review5
Steroid affected cytokines in aspirin‐exacerbated respiratory disease5
Antibody responses to the host microbiome in chronic rhinosinusitis5
Smell impairment in patients with allergic rhinitis5
Chronic intranasal corticosteroid treatment induces degeneration of olfactory sensory neurons in normal and allergic rhinitis mice5
Characterization of the tumor immune microenvironment of sinonasal squamous‐cell carcinoma5
Recurrence patterns among patients with sinonasal mucosal melanoma: A multi‐institutional study5
Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID‐19) patients: an observational study5
Long‐term quality‐of‐life impairment in patients with more than 1‐year COVID‐19–related olfactory dysfunction5
Efficacy of inferior turbinate reduction in pediatric patients: a prospective analysis4
Systematic review of olfactory outcomes after nasoseptal flap harvest for endoscopic skull base surgery: Does using cold steel or olfactory strip preservation matter?4
Work productivity and activity impairment in patients with chronic rhinosinusitis undergoing endoscopic sinus surgery—A prospective, multi‐institutional study4
Gender gap among rhinology and skull base surgeons4
Are nonsteroidal anti‐inflammatory drugs effective enough for postoperative pain control after functional endoscopic sinus surgery and septoplasty? A randomized, controlled study4
Does air pollutant exposure impact disease severity or outcomes in chronic rhinosinusitis?4
Chitogel following endoscopic sinus surgery promotes a healthy microbiome and reduces postoperative infections4
Pharmacokinetic‐based failure of a detergent virucidal for severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) nasal infections: A preclinical study and randomized controlled trial4
3D printing for virtual surgical planning of nasoseptal flap skull‐base reconstruction: A proof‐of‐concept study4
Opioid use after endoscopic skull base surgery: A descriptive, prospective, longitudinal cohort study4
Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study4
4
Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis4
The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey4
Health‐care utilization for sinusitis after pneumococcal vaccination in patients with low antibody titers4
Bacterial colonization differences between central compartment atopic disease and eosinophilic chronic rhinosinusitis4
Psychometric properties of the brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis4
Objective sleep measures after endoscopic sinus surgery in patients with chronic rhinosinusitis4
Dysbiosis in aspirin‐exacerbated respiratory disease4
Utility of a LangChain and OpenAI GPT‐powered chatbot based on the international consensus statement on allergy and rhinology: Rhinosinusitis4
Effect of nasal fluticasone exhalation delivery system on Eustachian tube dysfunction4
American Rhinologic Society Expert Practice Statements: methodology and approval process4
The possibility of short‐term hypothalamic‐pituitary‐adrenal axis suppression with high‐volume, high‐dose nasal mometasone irrigation in postsurgical patients with chronic rhinosinusitis4
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up4
4
Evolving concepts in the perioperative management of obstructive sleep apnea after endoscopic skull base surgery4
A social media analysis examining new‐age devices of the rhinology industry4
0.045424938201904